Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Opsens Inc TSX: OPS-T

Today's Change
Volume
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 1.92
Day High 1.99
Open:1.95
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
OpSens Inc focuses on interventional cardiology, offering an advanced optical-based pressure guidewire which aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada. OpSens is also involved in industrial activities in developing, manufacturing, and installing innovative fiber optic sensing solutions for critical application.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Latest Press Releases

OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain
- CNW Group - Wed Apr 21, 6:00AM CDT
CNW Group - CMTX
Wed Apr 21, 6:00AM CDT
OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain
OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues
- CNW Group - Wed Apr 14, 6:01AM CDT
CNW Group - CMTX
Wed Apr 14, 6:01AM CDT
OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues
OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III
- CNW Group - Wed Apr 7, 6:00AM CDT
CNW Group - CMTX
Wed Apr 7, 6:00AM CDT
OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.68 +17.26% increase
on 04/21/21
Period Open:1.71
Price movement based on the high, low and last over the given period.
2.25 -12.44% decrease
on 05/10/21
+0.26 (+15.20%) increase
since 04/12/21
3-Month 1.45 +35.86% increase
on 03/05/21
Period Open:1.89
Price movement based on the high, low and last over the given period.
2.25 -12.44% decrease
on 05/10/21
+0.08 (+4.23%) increase
since 02/12/21
52-Week 0.59 +233.90% increase
on 05/15/20
Period Open:0.63
Price movement based on the high, low and last over the given period.
2.36 -16.53% decrease
on 01/20/21
+1.34 (+212.70%) increase
since 05/12/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies